Condition: Patent Foramen Ovale · Cryptogenic Stroke · Older Patients · Sponsor: Josep Rodes-Cabau
Patent foramen ovale PFO closure has been shown to reduce the risk of stroke in patients with recurrent stroke. However, the majority of existing clinical studies in this field excluded patients over the age of 60 years. Data in older patients is limited and since the population ages and stroke remains a major cause of death and morbidity, randomized clinical trials are needed to better assess the benefit of PFO closure in this elderly population. Therefore, this study proposal sought to determine the efficacy of PFO closure for the prevention of recurrent stroke in older patients with PFO and cryptogenic stroke.
This description comes directly from the study's public registry record.
Josep Rodes-Cabau, MD, PhD · 4186568711 · josep.rodes@criucpq.ulaval.ca
Melanie Cote, MSc · 4186568711 · melanie.cote@criucpq.ulaval.ca
Always discuss trial participation with your own doctor first.
| IUCPQ-UL | Québec, Quebec, Canada | Active Not Recruiting |
| IUCPQ | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05907694